|
TMEM33 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.2804999999515E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.09949999607772E-08 |
| Normal-vs-Stage2 |
2.226200E-02 |
| Normal-vs-Stage3 |
1.155570E-02 |
| Normal-vs-Stage4 |
9.124400E-01 |
| Stage1-vs-Stage2 |
4.125200E-01 |
| Stage1-vs-Stage3 |
3.120400E-01 |
| Stage1-vs-Stage4 |
2.841700E-02 |
| Stage2-vs-Stage3 |
9.576600E-01 |
| Stage2-vs-Stage4 |
2.201200E-01 |
| Stage3-vs-Stage4 |
2.043600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.62050000038516E-07 |
| Normal-vs-AfricanAmerican |
8.40530000000284E-05 |
| Normal-vs-Asian |
1.715630E-01 |
| Caucasian-vs-AfricanAmerican |
9.152800E-01 |
| Caucasian-vs-Asian |
7.152000E-01 |
| AfricanAmerican-vs-Asian |
7.357200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.48449999959333E-07 |
| Normal-vs-Female |
7.753300E-04 |
| Male-vs-Female |
3.572000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.385000E-03 |
| Normal-vs-Extreme_Weight |
2.28029999999046E-05 |
| Normal-vs-Obese |
5.171500E-04 |
| Normal-vs-Extreme_Obese |
6.956200E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.412800E-01 |
| Normal_Weight-vs-Obese |
9.723000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.180200E-01 |
| Extreme_Weight-vs-Obese |
4.574200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.051800E-01 |
| Obese-vs-Extreme_Obese |
8.926800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.023700E-04 |
| Normal-vs-Age(41-60Yrs) |
1.386490E-04 |
| Normal-vs-Age(61-80Yrs) |
2.83170000003885E-07 |
| Normal-vs-Age(81-100Yrs) |
2.036800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.807600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.075800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.878200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.374970E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.513600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.471600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.0125000005079E-07 |
| Normal-VS-Type2 PRCC |
1.587620E-04 |
| Normal-VS-KIRP CIMP |
7.235800E-02 |
| Normal-VS-Unclassified PRCC |
1.058820E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.812400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.808600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.035800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.731600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.671000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.490200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.82679999910707E-08 |
| Normal-vs-N1 |
9.682000E-02 |
| Normal-vs-N2 |
5.443200E-01 |
| N0-vs-N1 |
1.228010E-01 |
| N0-vs-N2 |
2.592400E-01 |
| N1-vs-N2 |
9.337600E-01 |
|
|
